Similar articles

• What do we know about insulin resistance and glucose metabolism in patients with schizophrenia treated with antipsychotics?

  Arranz B, San L. Arranz B, et al. J Clin Psychiatry. 2007 May;68(5):800-1; author reply 801-2. doi: 10.4088/jcp.v68n0522d. J Clin Psychiatry. 2007. PMID: 17508432 No abstract available.
• Atypical antipsychotics and glucose homeostasis.

  Bergman RN, Ader M. Bergman RN, et al. J Clin Psychiatry. 2005 Apr;66(4):504-14. doi: 10.4088/jcp.v66n0414. J Clin Psychiatry. 2005. PMID: 15816794 Review.
• Insulin resistance index and counter-regulatory factors during olanzapine or risperidone administration in subjects with schizophrenia.

  Baptista T, Martinez M, Lacruz A, Arellano A, Mendoza S, Beaulieu S, Hernández L, Contreras Q, Galeazzi T, Vargas D. Baptista T, et al. Schizophr Res. 2007 Jan;89(1-3):350-2. doi: 10.1016/j.schres.2006.08.020. Epub 2006 Oct 6. Schizophr Res. 2007. PMID: 17029751 Clinical Trial. No abstract available.
• Serum free Fatty acids and glucose metabolism, insulin resistance in schizophrenia with chronic antipsychotics.

  Wang CJ, Zhang ZJ, Sun J, Zhang XB, Mou XD, Zhang XR, Shang XF, Zhang TQ. Wang CJ, et al. Biol Psychiatry. 2006 Dec 15;60(12):1309-13. doi: 10.1016/j.biopsych.2006.03.014. Epub 2006 May 2. Biol Psychiatry. 2006. PMID: 16650386
• Abnormalities of glucose metabolism associated with atypical antipsychotic drugs.

  Newcomer JW. Newcomer JW. J Clin Psychiatry. 2004;65 Suppl 18:36-46. J Clin Psychiatry. 2004. PMID: 15600383 Review.